Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
levomefolate + docosahexaenoic acid
- Development stage
- Unknown
- Lead developer
- Blue Heron Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Folasync DHA is a nutritional supplement developed by Blue Heron Pharmaceuticals, specifically formulated for prenatal and postnatal nutritional support. It combines levomefolate (the biologically active form of folate, also known as L-methylfolate) with docosahexaenoic acid (DHA), an essential omega-3 fatty acid. Levomefolate is critical for DNA synthesis, red blood cell formation, and the prevention of neural tube defects. Unlike synthetic folic acid, levomefolate does not require enzymatic conversion by methylenetetrahydrofolate reductase (MTHFR), making it particularly beneficial for individuals with MTHFR genetic polymorphisms. DHA is a primary structural component of the human brain, cerebral cortex, and retina, playing a vital role in the neurological and visual development of the fetus and infant during pregnancy and lactation.
- Brand names
- Folasync DHA
- Other names
- L-methylfolate + DHA6S-5-methyltetrahydrofolate + docosahexaenoic acid
02
Targets
FOLR1 (FRα)FFAR4 (Free fatty acid receptor 4)
Beyond the preview
Go deeper on levomefolate + docosahexaenoic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on levomefolate + docosahexaenoic acid.